Cartesian Therapeutics Inc Stock Ownership - Who owns Cartesian Therapeutics?

Insider buying vs selling

Have Cartesian Therapeutics Inc insiders been buying or selling?
Timothy A. SpringerDirector2024-03-261,970,443$1.46
Timothy A. SpringerDirector2024-03-18800$0.61
Timothy A. SpringerDirector2024-03-1819,044$0.60
Timothy A. SpringerDirector2024-03-15537,500$0.59
Timothy A. SpringerDirector2024-03-151,200$0.56
Timothy A. SpringerDirector2024-03-142,000$0.53
Timothy A. SpringerDirector2024-03-14648,372$0.54
Timothy A. SpringerDirector2024-03-133,200$0.58
Timothy A. SpringerDirector2024-03-121,200$0.61
Timothy A. SpringerDirector2024-03-111,200$0.65

1 of 3

RNAC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RNAC insiders and whales buy or sell their stock.

RNAC Shareholders

What type of owners hold Cartesian Therapeutics Inc stock?
Fmr LLC80.74%14,369,071$327.61MInstitution
Artal Group Sa51.34%9,136,635$208.32MInstitution
Timothy A. Springer44.15%7,856,598$179.13MInsider
Blackrock Inc40.76%7,253,975$165.39MInstitution
Vanguard Group Inc35.49%6,315,113$143.98MInstitution
Carsten Brunn27.62%4,916,056$112.09MInsider
Elizabeth Hoge19.91%3,543,264$80.79MInsider
Murat Kalayoglu19.91%3,543,264$80.79MInsider
Amir Nashat15.04%2,676,234$61.02MInsider
Geode Capital Management LLC14.04%2,498,949$56.98MInstitution

1 of 3

RNAC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNAC54.76%45.24%Net BuyingNet Buying
SLRN74.37%25.63%Net SellingNet Selling
NGNE43.00%57.00%Net Buying
CABA92.36%7.64%Net Buying

Cartesian Therapeutics Stock Ownership FAQ

Who owns Cartesian Therapeutics?

Cartesian Therapeutics (NASDAQ: RNAC) is owned by 289.15% institutional shareholders, 238.86% Cartesian Therapeutics insiders, and 0.00% retail investors. Timothy A. Springer is the largest individual Cartesian Therapeutics shareholder, owning 7.86M shares representing 44.15% of the company. Timothy A. Springer's Cartesian Therapeutics shares are currently valued at $179.13M.

If you're new to stock investing, here's how to buy Cartesian Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.